Paula Cannon speaks at the 2011CIRM Grantee Meeting about a stem cell-based therapy for HIV/AIDS. Cannon is a co-principle investigator on a disease team that has the goal of engineering a person’s own bone marrow to make the cells resistant to HIV. CIRM awarded a million grant to support the program.
John Zaia, MD, spoke at the “Spotlight on Disease Team Awards: HIV/AIDS,” an educational event presented at the CIRM Governing Board meeting on April 29, 2010. Zaia is the chairman in department of virology and he holds the Aaron D. and Edith Miller Chair for Gene Therapy at the Beckman Research Institute at the City of Hope. Zaia was introduce by Jeff Sheehy, a patient advocate member of the CIRM Governing Board. The CIRM-hosted event was presented at City of Hope in Duarte, California. To view the other videos in this playlists, go to: www.youtube.com
Blood transplant ‘cures man of HIV’
A leukaemia patient has been cured of the HIV Aids virus with a bone marrow transplant it has been claimed. Read more on Press Assoc. via Yahoo! UK & Ireland News
Invito studies show HUCBs provide trophic effect enhancing survival and maturation of hippocampal neurons
Laboratory culture studies examining the activity of human umbilical cord blood cells on experimental models of central nervous system aging, injury and disease, have shown that HUCBs provide a ‘trophic effect’ that enhances survival and maturation of hippocampal neurons harvested from both young and old laboratory animals. Read more on News-Medical-Net
Anchor Therapeutics announces publication demonstrating pepducin technology as novel approach to target GPCR
Anchor Therapeutics today announced the publication of new research in the Proceedings of the National Academy of Sciences USA. The paper describes the identification and characterization of a pepducin-based allosteric agonist that targets CXCR4, a chemokine G protein-coupled receptor found on hematopoietic stem cells and other bone marrow-derived cells. Read more on News-Medical-Net
